Squirrel Hill, Wabash Street, and Cranberry, Pittsburgh, PA
An estimated 2.7 million to 3.9 million Americans have hepatitis C, according to the Centers for Disease Control and Prevention. It usually develops slowly over decades, with no symptoms until serious damage is done. Without treatment, the virus can cause liver failure and liver cancer, often requiring a liver transplant or resulting in death.
For decades, hepatitis C treatment required a year of grueling shots and pills that gave patients flu-like symptoms and still barely cured half of them. Starting late in 2013, Gilead revolutionized treatment with the first pill-only medicines that brought cures in 12 weeks for more than 90 percent of patients.
This medication is a combination of glecaprevir and pibrentasvir and is used to treat chronic (long-lasting) hepatitis C, a viral infection of the liver. ... Chronic hepatitis C infection can cause serious liver problems such as scarring (cirrhosis) or liver cancer.
MAVYRET IS THE FIRST 8-WEEK CURE* APPROVED FOR ALL COMMON TYPES OFHEP C... In clinical trials, MAVYRET was taken once daily with food. Cure* rates varied from 92% to 100% based on the subtype of hep C and previous treatment experience.